NO970252L - Mixture for nasal administration of a drug - Google Patents

Mixture for nasal administration of a drug

Info

Publication number
NO970252L
NO970252L NO970252A NO970252A NO970252L NO 970252 L NO970252 L NO 970252L NO 970252 A NO970252 A NO 970252A NO 970252 A NO970252 A NO 970252A NO 970252 L NO970252 L NO 970252L
Authority
NO
Norway
Prior art keywords
drug
mixture
nasal administration
nasal
administration
Prior art date
Application number
NO970252A
Other languages
Norwegian (no)
Other versions
NO970252D0 (en
Inventor
Peter Watts
Lisbeth Illum
Original Assignee
Danbiosyst Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst Uk Ltd filed Critical Danbiosyst Uk Ltd
Publication of NO970252L publication Critical patent/NO970252L/en
Publication of NO970252D0 publication Critical patent/NO970252D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
NO970252A 1994-07-26 1997-01-21 Mixture for nasal administration of a drug NO970252D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414966A GB9414966D0 (en) 1994-07-26 1994-07-26 Pharmaceutical compositions for the nasal administration of antiviral agents
PCT/GB1995/001735 WO1996003142A1 (en) 1994-07-26 1995-07-24 Drug delivery composition for the nasal administration of antiviral agents

Publications (2)

Publication Number Publication Date
NO970252L true NO970252L (en) 1997-01-21
NO970252D0 NO970252D0 (en) 1997-01-21

Family

ID=10758832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970252A NO970252D0 (en) 1994-07-26 1997-01-21 Mixture for nasal administration of a drug

Country Status (7)

Country Link
EP (1) EP0773791A1 (en)
JP (1) JPH10506376A (en)
CA (1) CA2195639A1 (en)
FI (1) FI970331A0 (en)
GB (2) GB9414966D0 (en)
NO (1) NO970252D0 (en)
WO (1) WO1996003142A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879712A (en) 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
WO1997032596A1 (en) * 1996-03-06 1997-09-12 Boehringer Ingelheim Pharmaceuticals, Inc. Intercellular adhesion molecule powder formulation
GB9700624D0 (en) * 1997-01-14 1997-03-05 Danbiosyst Uk Drug delivery composition
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
WO1999003452A1 (en) * 1997-07-18 1999-01-28 Bayer Corporation Methods of removing residual solvent from nasal drug delivery compositions
AU744328B2 (en) * 1997-10-31 2002-02-21 Cp Kelco Aps Controlled release compositions comprising gellan gum gels
EP1035833B1 (en) * 1997-12-02 2005-08-31 Archimedes Development Limited Compositions for nasal administration
GB0015682D0 (en) * 2000-06-28 2000-08-16 Bristol Myers Squibb Co Sprayable wound care composition
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
DE102008007759B4 (en) 2007-12-04 2009-09-24 Atlantichem Gmbh Agent for preventing discoloration when washing textiles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0314863B1 (en) * 1987-11-02 1994-12-07 Baylor College Of Medicine Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation
ES2141076T3 (en) * 1988-09-01 2000-03-16 Bayer Ag HUMAN RHINOVIRUS RECEPTOR PROTEIN INHIBITING VIRUS INFECTIVITY.
SE8804164A0 (en) * 1988-11-17 1990-05-18 Per Prisell Pharmaceutical preparation
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
WO1993006842A1 (en) * 1991-10-02 1993-04-15 Boehringer Ingelheim Pharmaceuticals, Inc. Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
CA2116109A1 (en) * 1992-06-22 1994-01-06 Jeffrey M. Greve Multimeric forms of human rhinovirus receptor protein
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system

Also Published As

Publication number Publication date
GB2305606A (en) 1997-04-16
GB9700817D0 (en) 1997-03-05
JPH10506376A (en) 1998-06-23
FI970331A (en) 1997-01-27
EP0773791A1 (en) 1997-05-21
FI970331A0 (en) 1997-01-27
WO1996003142A1 (en) 1996-02-08
AU2988695A (en) 1996-02-22
AU707462B2 (en) 1999-07-08
NO970252D0 (en) 1997-01-21
GB2305606B (en) 1998-08-05
GB9414966D0 (en) 1994-09-14
CA2195639A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
NO975931D0 (en) Mixture for administration of drug
NO20002851D0 (en) Compositions for nasal administration of drugs
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
NO20001219D0 (en) Mixture for drug administration
US5506203C1 (en) Systemic administration of a therapeutic preparation
GB2303064B (en) Medicament for nasal administration
NO970252D0 (en) Mixture for nasal administration of a drug
KR950700754A (en) New drugs (NOVEL MEDICAMENT)
NO953549D0 (en) Infusion set for an intermittent or continuous delivery of a therapeutic substance
IS2537B (en) Medicinal product for intravenous administration
NO175515C (en) Process for the preparation of a pharmaceutical preparation for percutaneous delivery
NO972798D0 (en) Intravaginal drug delivery devices for administration of 17 <beta> -estradiol precursors
MX9101175A (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
NO950238D0 (en) Mixture for delivery of drug to the lymphatic system
NO173486C (en) Procedure for Preparing a Pharmaceutical Preparation for Transdermal Drug Administration
NO20004234L (en) Device for Õ indicate administration of a drug
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
NO177485C (en) Process for the preparation of a pharmaceutical inhalation preparation
NO179396C (en) Process for the preparation of a drug administration form for ruminants
NO981537D0 (en) Process for the preparation of antimalarial drugs
NO20000811D0 (en) Method of selecting a drug
FI944460A0 (en) Process for the preparation of a drug preparation
IT1223132B (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
FI950065A (en) A device for administering a medicament and a method of making such a device
GB9304549D0 (en) Apparatus for administration of drugs

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application